SCHEMBL25324367

SCHEMBL25324367

Cn1ccc(-c2ccc(Cl)cn2)n1

nearest known ligand 0.43

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 1/20 0.42
KEAP1 Q14145 1/20 0.40
JMJD6 Q6NYC1 6/20 0.39
KCNH2 Q12809 1/20 0.38
GRIN2B Q13224 1/20 0.38
NPC1 O15118 3/20 0.37
CNR2 P34972 1/20 0.37
CYP19A1 P11511 1/20 0.37
KDM5B Q9UGL1 1/20 0.36
CCR1 P32246 1/20 0.35
CCR5 P51681 1/20 0.35
CCR8 P51685 1/20 0.35
HDAC6 Q9UBN7 1/20 0.35
RAB9A P51151 2/20 0.35
GRM5 P41594 1/20 0.35
SCN4A P35499 1/20 0.34
MAPT P10636 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30509528 1.00 KMT2A (0.42) KMT2AKEAP1JMJD6KCNH2GRIN2B
SCHEMBL42126 0.78 CCR1 (0.64) KMT2AKEAP1JMJD6NPC1CYP19A1
SCHEMBL197456 0.78 CCR1 (0.46) CNR2CCR1CCR5CCR8HDAC6
SCHEMBL31504098 0.78 CCR1 (0.46) CNR2CCR1CCR5CCR8HDAC6
SCHEMBL29972469 0.77 KMT2A (0.42) KMT2AKEAP1JMJD6KCNH2NPC1
SCHEMBL2147232 0.77 KMT2A (0.42) KMT2AKEAP1JMJD6KCNH2NPC1
SCHEMBL28316565 0.77 KEAP1 (0.58) KMT2AKEAP1JMJD6CYP19A1KDM5B
SCHEMBL16561247 0.77 SCN4A (0.49) KMT2AKEAP1JMJD6CYP19A1GRM5
SCHEMBL30509507 0.77 SCN4A (0.49) KMT2AKEAP1JMJD6CYP19A1GRM5
SCHEMBL12461122 0.77 KMT2A (0.42) KMT2AKEAP1JMJD6CYP19A1KDM5B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230339900-A1 CASEIN KINASE 1 DELTA MODULATORS JANSSEN PHARMACEUTICA NV (BE) 2023-10-26 US disclosed
EP-4214199-A1 CASEIN KINASE 1 DELTA MODULATORS JANSSEN Pharmaceutica NV (BE) 2023-07-26 EP disclosed
CN-116490503-A Casein kinase 1 delta modulators 詹森药业有限公司 2023-07-25 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230339900-A1 CASEIN KINASE 1 DELTA MODULATORS CSNK1D, CSNK1A1, CSNK2A1 KMT2A 772/4885KEAP1 1550/4885JMJD6 3200/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.